Renovated Pharma Unit Available for Investment or Sale

Established in 1988, this pharmaceutical manufacturing unit specializing in liquid oral formulations operated successfully until 2012 and has now resumed operations. The owner has recently invested capital to modernize and renew the entire setup, but additional growth investment is required to fully run and scale production. The facility covers a 4,000 sq. ft. plant area, situated on a long-term leased property with an economical yearly rent of ₹1 Lakh, secured until 2037. This presents a cost-effective operational foundation with low overheads. While the primary focus is securing an active financial partner or investor to drive business growth, the owner is also open to an outright sale of the setup. This is an ideal turnkey opportunity for investors or healthcare companies looking to acquire or partner with a renewed manufacturing facility featuring long-term lease stability.